Arun Tholudur
About Arun Tholudur
Arun Tholudur serves as the Senior Vice President of Pharmaceutical Development and Manufacturing at Arcus Biosciences, where he has worked since 2022. With over 20 years of experience in the biotechnology industry, he has a strong background in process development and commercialization of biopharmaceutical products.
Work at Arcus Biosciences
Arun Tholudur serves as the Senior Vice President of Pharmaceutical Development and Manufacturing at Arcus Biosciences, a position he has held since 2022. In this role, he is responsible for overseeing the process development, manufacturing, and commercialization of both small and large molecule products. Prior to this, he was the Vice President of Antibody Development and Manufacturing at the same organization from 2021 to 2022. Both positions are based in Hayward, California.
Education and Expertise
Arun Tholudur earned a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Madras, from 1989 to 1993. He furthered his education at the University of Colorado Boulder, where he obtained both a Master of Science and a Ph.D. in Chemical Engineering between 1993 and 1998. He has over 20 years of experience in Chemistry, Manufacturing, and Controls (CMC) within the biotechnology industry, demonstrating expertise in leading cross-functional teams for the commercialization of biopharmaceutical products.
Background
Before joining Arcus Biosciences, Arun Tholudur held several positions at Amgen, including Principal Engineer in Process Development, Director of Global Operations Planning and CMC Lifecycle Management, and Executive Director for various process development roles. He also worked at Fujifilm Diosynth Biotechnologies as a Staff Scientist in Process Development and served as a Post-doctoral Researcher at the National Renewable Energy Laboratory. His career spans over two decades in the biotechnology sector.
Achievements
Throughout his career, Arun Tholudur has demonstrated a track record of leading cross-functional teams in the successful commercialization of biopharmaceutical products. His leadership roles at Amgen included significant assignments such as Operations Lead for the Amgen-Lilly COVID Antibody Collaboration. His extensive experience in process development and manufacturing has contributed to advancements in both small and large molecule products within the industry.